Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Saturday, September 25, 2021
Clean Cells, part of the Clean Biologics group, a provider of biopharmaceutical product quality control services and manufacturer of starting materials, announced an investment of €13M ($15.3M) for a new production facility in Montaigu-Vendée. By ...
read more
Clearmind Medicine Inc. announced an agreement with IMP Clinical Supply Services.
IMP will be responsible for the global clinical supply chain of Clearmind’s proprietary drug candidate CMND-100 from manufacture to the various clinical sites.
read more
Wednesday, September 06, 2023
Clearmind Medicine Inc., a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced that the company has entered into a Clinical Trial Agreement with Johns ...
read more
Tuesday, December 19, 2017
ClearPath has initiated a third research collaboration with Astellas Pharma to combat infections.
read more
Clearside Biomedical announced Arctic Vision has acquired an exclusive license for the commercialization and development of XIPERE in Greater China and South Korea.
read more
Clearside Biomedical announced an update to the XIPERE NDA resubmission timeline and to its commercialization and development partnership with Bausch Health and Bausch + Lomb, its global eye health business.
read more
ClinCapture will begin offering EDC at no cost for specific clinical trials investigating COVID-19 Coronavirus.
read more
MediciNova will be using Captivate EDC to perform a clinical trial to target severe COVID-19.
read more
Monday, November 08, 2021
Clinical Ink announces it's acquisition of Digital Artefacts.
read more
Clinical Ink announced its acquisition by GI Partners, a private equity investment firm.
read more
Clinical ink announced the appointment of Andrew Kraus as Chief Technology Officer. In this role, Kraus will lead the development of the company’s expanding technology portfolio to support clinical trials.
read more
Clinical Ink has made a commitment to donate several hundred mobile phones and tablets to Thrive Behavioral Health for individual and family mental tele-health services.
read more
Tuesday, February 28, 2023
Clinical ink, a global life science technology company, announced a strategic alliance with The Boston Clinical Research Institute (BCRI), an Academic Research Organization (ARO) based in Boston, Massachusetts.
read more
Clinical Ink, a global clinical trial technology company, announced the hiring of Janette Morgan as EVP, General Manager, EMEA.
read more
Clinical Ink has announced the hiring of CCO Chris Crucitti, COO Brian Donahue, and VP Project Operations Bill Barrasso.
read more